Delivery Order SPE2DB22D9311-SPE2DB25FP7AE
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,714.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the specialty pharmaceutical product Kcentra. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,477.76 by the Defense Logistics Agency (DLA) on August 21, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical treatment. This delivery order was issued without a set-aside designation and carries an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $13,546.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 500-unit vials of Kcentra. The delivery order, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, employs firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,539.52 by the Defense Logistics Agency on August 18, 2025, for the supply of Kcentra 500 unit vials. The contract carries an ultimate completion date of September 9, 2025, and is not designated under any set-aside program. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,880.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 1,000 unit vials of the drug Kcentra. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,107.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is to provide Kcentra 500unit 1s, a specialized pharmaceutical product, with a period of performance through December 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- The Defense Logistics Agency awarded a $7,296.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 25, 2025, by the Defense Logistics Agency (DLA) for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used to reverse anticoagulation. The firm fixed-price delivery order has a ceiling value of $19,845.12 with an ultimate completion date of August 15, 2025. This award was issued without a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,977.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 500-unit vials of Kcentra, a blood coagulant medication, with a performance period ending on April 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, valued at up to $4,999,999, which enables...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,602.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the blood coagulant Kcentra, with a completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999...
- SPE2DB22D9311Indefinite Delivery Contract
- SPE2DB22D9311-SPE2DB25FP7AEDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,213.76 by the Defense Logistics Agency on August 26, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a prothrombin complex concentrate used to reverse warfarin anticoagulation. The delivery order carries an ultimate completion date of September 17, 2025, and was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense medical supply needs. The Defense Logistics Agency utilizes the DLA pharmaceutical supply programs to ensure consistent access to critical medications and biologics across military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier within this federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively while maintaining a robust portfolio of pharmaceutical deliveries. The company's previous contract awards demonstrate capability across diverse product categories including specialty medications, biologics, and medical consumables essential to military health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 8/26/25 |